Following the recent spike in the rate of Covid-19 infections in the country coupled with the dwindling vaccine stock, President Uhuru Kenyatta on Monday, April 12, 2021, held a crisis meeting.
Reports privy to the meeting indicate that the meeting delved majorly on the deteriorating Covid-19 situation and the foreseeable shortage of Astrazeneca vaccine.
This after the ministry of health projection predicted the remaining 1.02 million doses would only last for utmost 2 weeks, with the first group almost due for a second injection.
“We are working around the clock to find a solution. The stock we have at the moment can only last about 10 days, by which time the first batch of persons who received the jab would be due for their second injection.
“We will have the second doses that people need within the 12-week window instead of the eight weeks we had set. This means we are still within the timelines set by WHO (World Health Organisation),” stated Willis Akhwale, the chairman of the task force of Covid-19 Deployment and Vaccination.
The new development faces the first jab takers with a longer wait for the next batch, with reports underway of government efforts for a second batch to come.
“The President ordered us to ensure that the country receives its next batch of vaccines as soon as possible. What I can tell you is that we are racing against time to actualize the directive,” stated one of the officials who attended the meeting.
This comes at a time when India the leading producer of the vaccine halted its production due to the increase in the number of recent infections.
Reports further indicate that since India’s suspension, the country has in action seeking funds to import the vaccine from several other sources including the US, Netherlands, and Belgium.